Exact Mass: 279.06775880000004
Exact Mass Matches: 279.06775880000004
Found 65 metabolites which its exact mass value is equals to given mass value 279.06775880000004,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Cidofovir
Cidofovir is only found in individuals that have used or taken this drug. It is an injectable antiviral medication for the treatment of cytomegalovirus (CMV) retinitis in patients with AIDS. It suppresses CMV replication by selective inhibition of viral DNA synthesis. [Wikipedia]Cidofovir acts through the selective inhibition of viral DNA polymerase.Biochemical data support selective inhibition of CMV DNA polymerase by cidofovir diphosphate, the active intracellular metabolite of cidofovir. Cidofovir diphosphate inhibits herpesvirus polymerases at concentrations that are 8- to 600-fold lower than those needed to inhibit human cellular DNA polymerase alpha, beta, and gamma(1,2,3). Incorporation of cidofovir into the growing viral DNA chain results in reductions in the rate of viral DNA synthesis. J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AB - Nucleosides and nucleotides excl. reverse transcriptase inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C471 - Enzyme Inhibitor > C29575 - DNA Polymerase Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent D004791 - Enzyme Inhibitors
N-[4'-hydroxy-(E)-cinnamoyl]-L-aspartic acid
N-[4-hydroxy-(E)-cinnamoyl]-L-aspartic acid is a cocoa metabolite from gut microflora. It is found n urine. Constituent of Arabidopsis thalianaand is also found in roasted cocoa beans and coffee powder [CCD].
(2R,4S)-2-Aminoformyl-6-fluoro-spiro[chroman-4,4'-imidazolidine]-2',5'-dione
Fexinidazole
C12H13N3O3S (279.06775880000004)
P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01C - Agents against leishmaniasis and trypanosomiasis > P01CA - Nitroimidazole derivatives C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
Imepitoin
C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent Imepitoin (AWD 131-138) is a new low-affinity partial benzodiazepine receptor agonist with potent anticonvulsant and anxiolytic properties in rodent models.
3-(2-amino-4,6-dioxo-3,4,5,6-tetrahydro-pteridin-7-yl)-2-oxo-propionic acid methyl ester|Erythropterin-methylester
ZLJ-6
C12H13N3O3S (279.06775880000004)
N-[4-hydroxy-(E)-cinnamoyl]-L-aspartic acid
1-CYCLOPROPYL-6,7-DIFLUORO-5-METHYL-4-OXO-3-QUINOLINE CARBOXYLIC ACID
1-(4-CHLOROPHENYL)-3-MORPHOLINO-1H-PYRAZOL-5(4H)-ONE
1-[3-chloro-5-(trifluoromethyl)-2-pyridyl]-1,4-diazepane
4-[2-(chloromethyl)-4-(trifluoromethyl)phenyl]morpholine
(s)-(+)-3-(benzyloxycarbonyl)-5-oxo-4-oxazolidineacetic acid
Acetamide,2-chloro-N-(2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)-
4-[4-Chloro-3-(trifluoromethyl)phenyl]-4-piperidinol
(2-(BUTYLTHIO)-5-(TRIFLUOROMETHYL)PYRIDIN-3-YL)BORONIC ACID
C10H13BF3NO2S (279.07121040000004)
3-benzylhydroxy-6-hydroxymethylpyridine-2-carboxaldehyde hydrochloride
C14H14ClNO3 (279.06621640000003)
(2-(ISOBUTYLTHIO)-5-(TRIFLUOROMETHYL)PYRIDIN-3-YL)BORONIC ACID
C10H13BF3NO2S (279.07121040000004)
Acrylic acid-2-acrylamido-2-methyl propane sulfonic acid copolymer
C10H17NO6S (279.07765420000004)
It is used as a food additive .
4-Chloro-6-ethoxyquinoline-3-carboxylic acid ethyl ester
C14H14ClNO3 (279.06621640000003)
Letosteine
R - Respiratory system > R05 - Cough and cold preparations > R05C - Expectorants, excl. combinations with cough suppressants > R05CB - Mucolytics C78273 - Agent Affecting Respiratory System > C74536 - Mucolytic Agent D019141 - Respiratory System Agents > D005100 - Expectorants
[5-furan-2-yl-4-(2-methyl-allyl)-4 h-[1,2,4]triazol-3-ylsulfanyl]-acetic acid
C12H13N3O3S (279.06775880000004)
7-PHENYL-1-(PROP-2-YNYL)-1H-PYRIMIDO[4,5-D][1,3]OXAZINE-2,4-DIONE
Cytarabine hydrochloride
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D000890 - Anti-Infective Agents > D000998 - Antiviral Agents D009676 - Noxae > D000963 - Antimetabolites D000970 - Antineoplastic Agents Cytarabine hydrochloride, a nucleoside analog, causes S phase cell cycle arrest and inhibits DNA polymerase. Cytarabine inhibits DNA synthesis with an IC50 of 16 nM. Cytarabine hydrochloride has antiviral effects against HSV.
(+/-)-8,9-Difluoro-5-methyl-6,7-dihydro-1-oxo-1H,5H-bnezo[i,j]quinolizine-2-carboxylic acid
ETHYL 8-CHLORO-1-ETHYL-4-OXO-4H-QUINOLIZINE-3-CARBOXYLATE
C14H14ClNO3 (279.06621640000003)
methyl 1-cyclopropyl-6,7-difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylate
2-Amino-5-beta-D-ribofuranosyl-4(1H)-pyrimidinone hydrochloride
Ethyl 2-amino-4-(4-fluorophenyl)-5-methyl-thiophene-3-carboxylate
5-amino-2-(4-aminoanilino)benzenesulfonic acid
C12H13N3O3S (279.06775880000004)
3-(3-Fluoro-4-hydroxyphenyl)-7-hydroxy-1-naphthonitrile
C17H10FNO2 (279.06955320000003)
3-chloro-2,2-dimethyl-N-[4-(trifluoromethyl)phenyl]propanamide
Taribavirin hydrochloride
D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C254 - Anti-Infective Agent > C281 - Antiviral Agent
6-Fluoro-2,5-dioxo-2,3-dihydrospiro[chromene-4,4-imidazolidine]-2-carboxamide
Dimethyl 2-[[bis(methylsulfanyl)methylideneamino]methyl]butanedioate
(2S,4R)-2-Aminoformyl-6-fluoro-spiro[chroman-4,4-imidazolidine]-2,5-dione
But-3-enyl-[5-(4-chloro-phenyl)-3,6-dihydro-[1,3,4]thiadiazin-2-ylidene]-amine
Fexinidazole
C12H13N3O3S (279.06775880000004)
P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01C - Agents against leishmaniasis and trypanosomiasis > P01CA - Nitroimidazole derivatives C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
2-[4-(Trifluoromethoxy)phenyl]imidazo[1,2-a]pyrimidine
2-[2-(Butan-2-ylidene)hydrazino]-4-(4-chlorophenyl)-1,3-thiazole
1-S-(N-hydroxybut-3-enimidoyl)-1-thio-beta-D-glucopyranose
C10H17NO6S (279.07765420000004)
[5-(4-chlorophenyl)-1-isopropyl-1H-1,2,4-triazol-3-yl]acetic acid
2-Chloro-3-(3-methoxypropylimino)naphthalene-1,4-dione
C14H14ClNO3 (279.06621640000003)
6-Chloro-3-(3,3-dimethyl-2-oxobutyl)-1,4-benzoxazin-2-one
C14H14ClNO3 (279.06621640000003)
6-Chloro-3-(4-methyl-2-oxopentyl)-1,4-benzoxazin-2-one
C14H14ClNO3 (279.06621640000003)
Cidofovir
J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AB - Nucleosides and nucleotides excl. reverse transcriptase inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C471 - Enzyme Inhibitor > C29575 - DNA Polymerase Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent D004791 - Enzyme Inhibitors
desulfosinigrin
C10H17NO6S (279.07765420000004)
A desulfoglucosinolic acid resulting from the formal condensation of the thiol group of N-hydroxybut-3-enethioamide with beta-D-glucopyranose.
UCM-1306
UCM-1306 is a potent and orally active human dopamine D1 receptor allosteric modulator (PAM). UCM-1306 increases the endogenous dopamine (DA) maximal effect both in human and mouse D1 receptors. UCM-1306 is not only for improving motor symptoms but also for addressing the key comorbid cognitive impairment associated with long-term Parkinson’s disease (PD)[1].
2-{[1-hydroxy-3-(4-hydroxyphenyl)prop-2-en-1-ylidene]amino}butanedioic acid
(2s,3r,4s,5s,6r)-2-{[1-(hydroxyimino)but-3-en-1-yl]sulfanyl}-6-(hydroxymethyl)oxane-3,4,5-triol
C10H17NO6S (279.07765420000004)